A A Toye1, M E Dumas2, C Blancher1, A R Rothwell1, J F Fearnside1, S P Wilder1, M T Bihoreau1, O Cloarec2, I Azzouzi1, S Young1, R H Barton2, E Holmes2, M I McCarthy1, R Tatoud3, J K Nicholson2, J Scott3, D Gauguier4. 1. The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. 2. Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Faculty of Medicine, Imperial College London, London, UK. 3. Faculty of Medicine, Imperial College London, London, UK. 4. The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. gdomi@well.ox.ac.uk.
Abstract
AIMS/HYPOTHESIS: Complex changes in gene expression are associated with insulin resistance and non-alcoholic fatty liver disease (NAFLD) promoted by feeding a high-fat diet (HFD). We used functional genomic technologies to document molecular mechanisms associated with diet-induced NAFLD. MATERIALS AND METHODS: Male 129S6 mice were fed a diet containing 40% fat (high-fat diet, HFD) for 15 weeks. Glucose tolerance, in vivo insulin secretion, plasma lipid profile and adiposity were determined. Plasma metabonomics and liver transcriptomics were used to identify changes in gene expression associated with HFD-induced NAFLD. RESULTS: In HFD-fed mice, NAFLD and impaired glucose and lipid homeostasis were associated with increased hepatic transcription of genes involved in fatty acid uptake, intracellular transport, modification and elongation, whilst genes involved in beta-oxidation and lipoprotein secretion were, paradoxically, also upregulated. NAFLD developed despite strong and sustained downregulation of transcription of the gene encoding stearoyl-coenzyme A desaturase 1 (Scd1) and uncoordinated regulation of transcription of Scd1 and the gene encoding sterol regulatory element binding factor 1c (Srebf1c) transcription. Inflammatory mechanisms appeared to be stimulated by HFD. CONCLUSIONS/ INTERPRETATION: Our results provide an accurate representation of subtle changes in metabolic and gene expression regulation underlying disease-promoting and compensatory mechanisms, collectively contributing to diet-induced insulin resistance and NAFLD. They suggest that proposed models of NAFLD pathogenesis can be enriched with novel diet-reactive genes and disease mechanisms.
AIMS/HYPOTHESIS: Complex changes in gene expression are associated with insulin resistance and non-alcoholic fatty liver disease (NAFLD) promoted by feeding a high-fat diet (HFD). We used functional genomic technologies to document molecular mechanisms associated with diet-induced NAFLD. MATERIALS AND METHODS: Male 129S6 mice were fed a diet containing 40% fat (high-fat diet, HFD) for 15 weeks. Glucose tolerance, in vivo insulin secretion, plasma lipid profile and adiposity were determined. Plasma metabonomics and liver transcriptomics were used to identify changes in gene expression associated with HFD-induced NAFLD. RESULTS: In HFD-fed mice, NAFLD and impaired glucose and lipid homeostasis were associated with increased hepatic transcription of genes involved in fatty acid uptake, intracellular transport, modification and elongation, whilst genes involved in beta-oxidation and lipoprotein secretion were, paradoxically, also upregulated. NAFLD developed despite strong and sustained downregulation of transcription of the gene encoding stearoyl-coenzyme A desaturase 1 (Scd1) and uncoordinated regulation of transcription of Scd1 and the gene encoding sterol regulatory element binding factor 1c (Srebf1c) transcription. Inflammatory mechanisms appeared to be stimulated by HFD. CONCLUSIONS/ INTERPRETATION: Our results provide an accurate representation of subtle changes in metabolic and gene expression regulation underlying disease-promoting and compensatory mechanisms, collectively contributing to diet-induced insulin resistance and NAFLD. They suggest that proposed models of NAFLD pathogenesis can be enriched with novel diet-reactive genes and disease mechanisms.
Authors: Marc-Emmanuel Dumas; Richard H Barton; Ayo Toye; Olivier Cloarec; Christine Blancher; Alice Rothwell; Jane Fearnside; Roger Tatoud; Véronique Blanc; John C Lindon; Steve C Mitchell; Elaine Holmes; Mark I McCarthy; James Scott; Dominique Gauguier; Jeremy K Nicholson Journal: Proc Natl Acad Sci U S A Date: 2006-08-08 Impact factor: 11.205
Authors: I Shimomura; Y Bashmakov; S Ikemoto; J D Horton; M S Brown; J L Goldstein Journal: Proc Natl Acad Sci U S A Date: 1999-11-23 Impact factor: 11.205
Authors: Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon Journal: Nature Date: 2006-12-21 Impact factor: 49.962
Authors: Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon Journal: Proc Natl Acad Sci U S A Date: 2004-10-25 Impact factor: 11.205
Authors: Melanie D Spencer; Timothy J Hamp; Robert W Reid; Leslie M Fischer; Steven H Zeisel; Anthony A Fodor Journal: Gastroenterology Date: 2010-12-01 Impact factor: 22.682
Authors: N Stefan; A Peter; A Cegan; H Staiger; J Machann; F Schick; C D Claussen; A Fritsche; H-U Häring; E Schleicher Journal: Diabetologia Date: 2008-02-20 Impact factor: 10.122
Authors: Brendan R E Ansell; Malcolm J McConville; Louise Baker; Pasi K Korhonen; Samantha J Emery; Staffan G Svärd; Robin B Gasser; Aaron R Jex Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191
Authors: Soona Shin; Junko Wakabayashi; Melinda S Yates; Nobunao Wakabayashi; Patrick M Dolan; Susan Aja; Karen T Liby; Michael B Sporn; Masayuki Yamamoto; Thomas W Kensler Journal: Eur J Pharmacol Date: 2009-08-19 Impact factor: 4.432
Authors: Yaomin Hu; Pamela J Kaisaki; Karène Argoud; Steven P Wilder; Karin J Wallace; Peng Y Woon; Christine Blancher; Lise Tarnow; Per-Henrik Groop; Samy Hadjadj; Michel Marre; Hans-Henrik Parving; Martin Farrall; Roger D Cox; Mark Lathrop; Nathalie Vionnet; Marie-Thérèse Bihoreau; Dominique Gauguier Journal: BMC Med Genomics Date: 2009-07-09 Impact factor: 3.063